79
Views
9
CrossRef citations to date
0
Altmetric
Meeting Report

Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa

, , , , , , , , , , , , , & show all
Pages 149-152 | Received 25 Aug 2016, Accepted 01 Nov 2016, Published online: 18 Nov 2016
 

ABSTRACT

The second Medicines Utilization Research in Africa (MURIA) group workshop and symposium again brought researchers together from across Africa to improve their knowledge of drug utilization (DU) methodologies and exchange ideas to further progress DU research in Africa. This built on extensive activities from the first conference including workshops and multiple publications. Anti-infectives were again the principal theme for the 2016 symposium following the workshops. This included presentations regarding strategies to improve antibiotic utilization among African countries, such as point-prevalence studies, as well as potential ways to reduce self-purchasing of antibiotics. There were also presentations on antiretrovirals including renal function and the impact of policy changes. Concerns with adherence in chronic treatments as well as drug-drug interactions and their implications were also discussed. The deliberations resulted in a number of agreed activities including joint publications before the next MURIA conference in Namibia in 2017.

Acknowledgements

We would like to thank University of Botswana for the use of their excellent facilities and the administration team for greatly facilitating all aspects of the workshop. In addition, IUPHAR, Botswana Public Officers’ Medical Aid Scheme (BPOMAS) and the Ministry of Health in Botswana for their sponsorship. This meeting was also in part supported by a VR-Link grant from Swedish Research Council (VR-Link 2013-6710) to Amos Y Massele and Lars L Gustafsson.

Declaration of interest

There are no conflicts of interest from any author.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.